Speaker illustration

Mr Steven Kiddle

AstraZeneca, Cambridge (United Kingdom of Great Britain & Northern Ireland)

Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Biomarkers to improve prognostication in heart failure: what's new?

Thumbnail

ESC 365 is supported by

logo Novo Nordisk